[CHRS] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
15-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -100.94%
YoY- -20.24%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 70,774 64,979 77,063 91,524 74,568 58,716 32,436 67.98%
PBT -10,751 -12,921 102,875 -79,653 -40,021 -42,869 -75,729 -72.68%
Tax 0 0 1,464 -10,611 -380 11,560 -949 -
NP -10,751 -12,921 102,875 -79,653 -39,641 -42,869 -74,780 -72.45%
Tax Rate - - -1.42% - - - - -
Total Cost 81,525 77,900 -25,812 171,177 114,209 101,585 107,216 -16.65%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -15.19 -19.88 133.49 -87.03 -53.16 -73.01 -230.55 -83.60%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.09 -0.11 0.91 -0.71 -0.41 -0.49 -0.94 -78.98%
EPS Diluted -0.09 -0.11 0.82 -0.71 -0.41 -0.49 -0.94 -78.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.